Hangzhou AGS Medtech (688581.SH): The controlling shareholder, the actual controller, and the partnership enterprises controlled by them have committed not to reduce their holdings of the company's shares for 6 months.
Anjie Technology (688581.SH) announced that, based on firm confidence in the company's future development prospects and full recognition of the company's long-term investment value, and in order to support the company's sustained, stable, and healthy development and effectively safeguard the interests of the broad investor base, the company's controlling shareholder Hangzhou Yijia, actual controller Mr. Zhang Cheng, and the partnership enterprises controlled by him, Ningbo Jiayi and Hangzhou Dingjie, have committed that from November 19, 2026 to May 18, 2027, they will not reduce their directly held shares of the company by any means. During the above commitment period, any newly acquired shares of the company arising from the company's implementation of capitalization of capital reserve into share capital, distribution of stock dividends, rights issues, conversion of convertible corporate bonds into shares, and other such circumstances shall also be subject to the above non-reduction commitment.
Hangzhou AGS Medtech (688581.SH) announced that, based on firm confidence in the company's future development prospects and full recognition of the company's long-term investment value, and in order to support the company's sustained, stable, and healthy development and effectively safeguard the interests of the broad investor base, the company's controlling shareholder Hangzhou Yijia, actual controller Mr. Zhang Cheng, and the partnership enterprises controlled by him, Ningbo Jiayi and Hangzhou Dingjie, have committed that from November 19, 2026 to May 18, 2027, they will not reduce their directly held shares of the company by any means. During the aforementioned commitment period, any newly acquired shares of the company arising from the company's implementation of capitalization of capital reserve into share capital, distribution of stock dividends, rights issues, conversion of convertible corporate bonds into shares, and other such circumstances shall also be subject to the aforementioned non-reduction commitment.
Related Articles
SINOMAX GROUP (01418): For 2024 and 2025, under the regional revenue classification, the revenue attributable to the United States, together with the revenue attributable to products ultimately distributed to the United States, was approximately HK$1.677 billion and HK$1.933 billion, respectively.
CH NETCOMTECH (08071) Appoints Baker Tilly Hong Kong as New Auditor
CTF SERVICES (00659) intends to sell 100% equity interest in Man Cheuk, 25% equity interest in Jingzhu, and 25% equity interest in Yuezhao.
SINOMAX GROUP (01418): For 2024 and 2025, under the regional revenue classification, the revenue attributable to the United States, together with the revenue attributable to products ultimately distributed to the United States, was approximately HK$1.677 billion and HK$1.933 billion, respectively.
CH NETCOMTECH (08071) Appoints Baker Tilly Hong Kong as New Auditor
CTF SERVICES (00659) intends to sell 100% equity interest in Man Cheuk, 25% equity interest in Jingzhu, and 25% equity interest in Yuezhao.
